Surgical health tech start-up Pristyn Care said it has raised $53m in a Series-D round of funding led by US investment fund Tiger Global Management.
Pristyn Care’s valuation has since risen to $550m, more than doubling from the $250 million it had been valued at 6 months ago.
The latest round of funding is led by Tiger Global Sequoia Capital, Hummingbird Ventures and Epiq Capital.
The start-up, which specialises in secondary-care surgeries, is able to treat more than 50 conditions including DVTs, gallstones and cataracts using advanced medical technology such as lasers.
Harsimarbir Singh, co-founder, Pristyn Care said: “We welcome Tiger Global in our new investment round. This trust alongside participation from existing investors Sequoia Capital, Hummingbird Ventures and Epiq Capital, firms the vision of Pristyn Care.
“Our laser-sharp focus on scaling our surgery offerings and providing seamless patient experience in India has enabled us to have helped treat more than half a million patients in the past 2.5 years.
“With this new capital, we plan to expand our Surgery offerings in more cities and towns and attract international patients seeking treatment in India, treat new disease lines, and invest in brand building.
“We run more than 100 clinics and operate in more than 400 hospitals to impart patient-first care for our surgery patients”
In two and half years, the company has raised $28m from investors such as Sequoia Capital, Hummingbird, GreenOaks, Epiq Capital and Angel List.
Under its patient-first approach for all its Surgery patients, Pristyn Care provides end-to-end patient-first support services such as diagnostics support, complete health-insurance claim processing, hospital admission paperwork from the comfort of home. As well as cab pick-up and drop off at the surgery, medicine delivery at home and free post-surgery consultation.
Scott Shleifer from Tiger Global Management, said, “By using technology to deliver differentiated experiences and outcomes, Pristyn Care has built the leading consumer-centric surgery provider in India.
“The market opportunity is huge, and we couldn’t be more excited to partner with Harsimarbir (Harsh) and his team”
